1-4 of 4
Martha S. Linet, MD MPH
Close
Sort by
Journal Articles

Population-Based, Cause-Specific Risk of Non-Lymphoma Deaths Among 20,491 Adults with Classical Hodgkin Lymphoma (cHL) Treated with Initial Chemotherapy in the United States, 2000-2015

Graca M. Dores, MD, Rochelle E. Curtis, MA, Nicole H. Dalal, BA, Martha S. Linet, MD MPH, Lindsay M. Morton, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4034.
https://doi.org/10.1182/blood-2019-124831
Published: 2019
Journal Articles

Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012

Lindsay M Morton, PhD, Graca M. Dores, MD MPH, Meredith S Shiels, PhD, Martha S Linet, MD MPH, Jop C Teepen, Clara J.K. Lam, PhD, Margaret A. Tucker, MD, Rochelle E Curtis, MA
Journal: Blood
Blood (2015) 126 (23): 562.
https://doi.org/10.1182/blood.V126.23.562.562
Published: 2015
Journal Articles

Incidence and Patient Survival of Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs) in the United States: A Population-Based View of the Modern Diagnostic Era

Samer A Srour, MB ChB, MS, Susan S Devesa, MD, Lindsay M Morton, PhD, David P Check, Rochelle E Curtis, MA, Martha S Linet, MD MPH, Graca M Dores, MD MPH
Journal: Blood
Blood (2015) 126 (23): 2806.
https://doi.org/10.1182/blood.V126.23.2806.2806
Published: 2015
Journal Articles

Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Subsequent Multiple Myeloma among African-American and White Veterans in the U.S.

Ola Landgren, MD, PhD, Gloria Gridley, MS, Ingemar Turesson, MD, PhD, Neil E. Caporaso, MD, Lynn R. Goldin, PhD, Dalsu Baris, MD, PhD, Thomas R. Fears, PhD, Robert N. Hoover, MD, MPH, Martha S. Linet, MD, MPH
Journal: Blood
Blood (2005) 106 (11): 1541.
https://doi.org/10.1182/blood.V106.11.1541.1541
Published: 2005